Pharmaceutical Services Negotiating Committee (PSNC) - News updates


PCN engagement – implementation guidance and resources update (June 2019)

This update has been issued to support LPCs in engaging with Primary Care Networks (PCNs). It builds on PSNC Briefing 015/19: Supporting community pharmacies to engage with Primary Care Networks – potential actions for LPCs. PSNC has identified four phases of community pharmacy engagement with PCNs over the next 12 to 24 months. Focussing on...

PCSE invitation to contractors to test market entry online

Last month (May 2019), we shared with pharmacy contractors, the PCSE Engagement team’s invitation to test the market entry online portal. PCSE have confirmed that it will be hosting an initial introduction to user acceptance testing to Market Entry PCSE online on Tuesday 9th July at the Arlington Business Centre in Leeds, the session will...

PCN support: Think Pharmacy prospectuses relaunched

As part of PSNC’s ongoing support to help LPCs and community pharmacy contractors engage with Primary Care Networks (PCNs), the PSNC Think Pharmacy prospectuses have been reviewed and updated. A number of new prospectuses have also been published to add to the range of services covered. The prospectuses provide introductions to specific pharmacy services and...

Supply Status Update: EpiPen® 0.3mg and 0.15mg Adrenaline Auto-Injectors

Mylan’s manufacturing partner Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen®, recently experienced manufacturing issues resulting in interruptions in the production of EpiPen 0.3mg and EpiPen Jr 0.15mg Adrenaline Auto-Injectors (AAIs). To help manage stock availability until a steady supply resumes, Mylan has put in place a prescription-only process for EpiPen 0.3mg, meaning...

MHRA Drug Safety Update June 2019

Date issued: 19th June 2019 A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 12 Issue 11 June 2019:1) has been published and includes articles on: Direct-acting oral anticoagulants (DOACs): increased risk of recurrent thrombotic events in patients with antiphospholipid syndrome GLP-1 receptor agonists: reports of diabetic ketoacidosis when concomitant insulin...

June 2019 Price Concessions – 2nd update

Department of Health and Social Care (DHSC) has today granted the following list of price concessions: Drug Pack Size Price Concession Bumetanide 1mg tablets 28 £1.65 Candesartan 32mg tablets 28 £2.03 Carvedilol 3.125mg tablets 28 £1.17 Carvedilol 12.5mg tablets 28 £1.91 Carvedilol 25mg tablets 28 £2.50 Chloramphenicol 0.5% eye drops 10 £2.28 Co-careldopa 25mg/100mg tablets...

Drug Tariff Watch: July 2019 changes

The Preface lists additions, deletions and alterations to the Drug Tariff. Below is a quick summary of the changes due to take place from 1st July 2019. Part VIIIA additions Category C: Abacavir 600mg / Lamivudine 300mg tablets (30) – Lupin Healthcare (UK) Ltd Alirocumab 150mg/1ml solution for injection pre-filled disposable devices (2) – Praluent Alirocumab...

New NHS England and NHS Improvement PCN resources for LPCs and pharmacy teams

NHS England and NHS Improvement has published two key guidance documents around Primary Care Networks (PCNs): Primary Care Networks: A briefing for pharmacy teams This informative briefing is aimed at pharmacy teams across the NHS, including those working in community pharmacy. It contains key background information on PCNs: their structure, function, the role of clinical...

Quality Payments: Data published for February 2019 declaration

The NHS Business Services Authority (NHSBSA) has published declaration data relating to the February 2019 review point of the Quality Payments Scheme. The data provides a breakdown of the number of community pharmacy contractors who declared that they met the gateway criteria and the number of contractors who declared they met the individual quality criteria....

CPAF screening process a few weeks to go

Community pharmacy contractors are reminded that they have until Sunday 30th June 2019 to complete the 2019/20 Community Pharmacy Assurance Framework (CPAF) screening questionnaire. 56% of contractors had submitted the survey as of 18 June, which is broadly in line with previous years. Last year, 98% had completed it by the deadline. PSNC recommends that...